Title(s):
A021806 A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Investigator(s): Kathryn Leininger, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
A221805 Duloxetine To Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II To Phase III Study
Investigator(s): Kathryn Leininger, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
NRG-GI004/SWOG-S1610 Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination versus Single Agent Atezolizumab in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (NCT02997228)
Investigator(s): Kathryn Leininger, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
NRG-GI005 Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)
Investigator(s): Kathryn Leininger, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
NRG-GI008 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (Circulate-US)
Investigator(s):Kathryn Leininger, MD
Contact Information: McDowell Cancer Research at 330.344.6348
